Cite
T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.
MLA
Hu, Hao, et al. “T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.” Journal of Magnetic Resonance Imaging, vol. 56, no. 3, Sept. 2022, pp. 862–72. EBSCOhost, https://doi.org/10.1002/jmri.28088.
APA
Hu, H., Chen, L., Zhang, J., Chen, W., Chen, H., Liu, H., Shi, H., Wu, F., & Xu, X. (2022). T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation. Journal of Magnetic Resonance Imaging, 56(3), 862–872. https://doi.org/10.1002/jmri.28088
Chicago
Hu, Hao, Lu Chen, Jiu‐Lou Zhang, Wen Chen, Huan‐Huan Chen, Hu Liu, Hai‐Bin Shi, Fei‐Yun Wu, and Xiao‐Quan Xu. 2022. “T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.” Journal of Magnetic Resonance Imaging 56 (3): 862–72. doi:10.1002/jmri.28088.